Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Tilray Inc buy skatcup

Tilray Inc
Start price
€16.19
07.06.21 / 90%
Target price
€11.00
07.06.22
Performance (%)
-76.53%
End price
€3.80
07.06.22
Summary
This prediction ended on 07.06.22 with a price of €3.80. The BUY prediction by skatcup for Tilray Inc performed very badly with a performance of -76.53%. skatcup has 90% into this prediction

Tilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.

Performance without dividends (%)
Name 1w 1m 1y
Tilray Inc -14.105% -14.105% -78.620%
iShares Core DAX® 1.051% -1.833% 12.822%
iShares Nasdaq 100 -0.547% -3.738% 40.625%
iShares Nikkei 225® -1.778% -8.115% 16.092%
iShares S&P 500 0.002% -2.226% 28.387%

According to skatcup what are the pros and cons of Tilray Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Some uniques
Differentiated customer and product portfolio
Top 10 in its market
Undervalued
Small cyclical dependencies
Capable Management
Innovative
Growths faster than the competition
Known brand
Cons
Lower EBIT Margin than peer group
Higher risks for its business
EBIT decline/stagnation expected
Very low/no dividend yield expected
Bad rating

Comments by skatcup for this prediction

In the thread Tilray Inc diskutieren
Prediction Buy
Perf. (%) -76.53%
Target price 40.000
Change
Ends at 07.06.22

Buy mit Kursziel 40,0

skatcup 
0
Report Share
07.06.21
Prediction Buy
Perf. (%) -76.53%
Target price 30.000
Change
Ends at 07.06.22

Kursziel geändert auf 30,0

skatcup 
0
Report Share
10.07.21
Prediction Buy
Perf. (%) -76.53%
Target price 15.000
Change
Ends at 07.06.22

Kursziel geändert auf 15,0

skatcup 
0
Report Share
21.08.21
Prediction Buy
Perf. (%) -76.53%
Target price 13.000
Change
Ends at 07.06.22

Kursziel geändert auf 13,0

skatcup 
0
Report Share
03.10.21
Prediction Buy
Perf. (%) -76.53%
Target price 12.000
Change
Ends at 07.06.22

Kursziel geändert auf 12,0

skatcup 
0
Report Share
16.10.21
Prediction Buy
Perf. (%) -76.53%
Target price 15.000
Change
Ends at 07.06.22

Kursziel geändert auf 15,0

skatcup 
0
Report Share
15.11.21
Prediction Buy
Perf. (%) -76.53%
Target price 11.000
Change
Ends at 07.06.22

Kursziel geändert auf 11,0

skatcup 
0
Report Share
27.11.21
In the thread Trading Tilray Inc
Prediction Buy
Perf. (%) -76.53%
Target price 11.000
Change
Ends at 07.06.22

Die von skatcup gewählte maximale Laufzeit wurde überschritten

skatcup 
0
Report Share
07.06.22

Stopped prediction by skatcup for Tilray Inc

buy
Tilray Inc

Start price
Target price
Perf. (%)
€2.84
23.01.23
€3.00
23.01.24
-34.71%
24.01.24

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Some uniques
Differentiated customer and product portfolio
skatcup 
23.01.23 90%
buy
Tilray Inc

Start price
Target price
Perf. (%)
€3.35
18.07.22
€5.00
18.07.23
3.42%
23.07.22

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Some uniques
Differentiated customer and product portfolio
skatcup 
18.07.22 80%